CD4 and tuberculosis: In a randomized trial comprising 2600 hospitalized individuals diagnosed with HIV and TB, the incorporation of urine LAM-based evaluation through the utilization of the Alere TB-LAM test resulted in a noteworthy decrease in mortality among three specific segments of patients: those with diminished CD4+ T-cell numbers, profound anemia, or clinically presumed TB [32].